Revance Announces Positive Phase 2 Results for RT001 Botulinum Toxin Type A Topical Gel to Treat Axillary Hyperhidrosis

Source: Medical News (via PRIMEZONE) - Category: Pharmaceuticals Source Type: news
More News: Botox | Pharmaceuticals